RIKEN, equivalent to CNRS in France, is a national research and development agency based in Japan and is the largest comprehensive research institution in the country. After RIKEN symposium held in Belgium on February 14 where Dr Nathalie Maubon, our CEO, and Dr Meryl Roudaut, our stem cell and liver Read more…
During this time of celebrating the Chinese New Year, HCS Pharma extends its best wishes to all those observing this special occasion. This year, the transition to the Year of the Dragon promises to bring strength, courage, and growth opportunities. We take this opportunity to thank our partners, clients, and Read more…
A great way to ended the year 2023! The participation of Dr. Nathalie MAUBON and Dr. Meryl ROUDAUT to represent HCS Pharma at HACKOSAKA event in december 2023 in Japan was an excellent opportunity to once again promote the results of research with our extracellular matrix 3Dmodel, BIOMIMESYS.We are honored Read more…
HCS Pharma announces the closure of the “MIMLIVERonChip” project, funded by the French National Research Agency (ANR, project ANR 19 CE19-0020) and coordinated by BMBI Biomechanics and Bioengineering joint research unit (UTC/ CNRS), headed by Dr Cécile Legallais, CNRS research director. This project led to the publication of Taha Messelmani’s Read more…
Yesterday Julien Cicero defended his PhD thesis in OncoLille Institute, about the role of neurotrophins and related receptors in brain metastasis of triple negative breast cancer. What a great thesis defense, we enjoyed a lot his very clear presentation and his responses to the questions of the committee. Perfect time Read more…
In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D HydroscaffoldTM matrix BIOMIMESYS® could be useful for bioproduction. We will be happy to meet you at “8th Bioproduction congress“ on thursday and friday in Lyon, France. If Read more…
This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with the University of Technology of Compiègne (UTC) using the BIOMIMESYS® Liver hydroscaffold™ and HepG2/C3A (hepatocellular Read more…
In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D hydroscaffold matrix BIOMIMESYS® could be useful for bioproduction and then for cell therapy. We will be happy to meet you at ELRIG congress “Advancements in cell & Read more…
In Asia for a business trip, Nathalie Maubon, PhD, CEO & CSO of HCS Pharma, participated in a symposium during BioAsia event on late July, together with LumiSTAR Biotechnology (Taïwan) and Molecular Devices (USA). On this occasion, the 3 companies have highlighted their work on hiPSCs (human induced Pluripotent Stem Read more…
The Perseid meteor shower which is taking place on the 14th of July and will finish on the 1st September will reach its high point between the 10 and the 14th of August. Debris from comet Swift-Tuttle, which has broken off from its tail, is falling and should end its Read more…
Rehovot (Israel) London (UK) and Lille (France) Vidac Pharma is a clinical stage biopharmaceutical company dedicated to discovering and developing First-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. Vidac Pharma and HCS Pharma announce cooperative agreement on acceleration of pre-clinical assays for Vidac Pharma Read more…
We are happy to share that Nathalie Maubon, PhD, our CEO/CSO is currently attending BioAsia Taiwan, organized in Taipei. The event aims at building on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities Read more…
Organisms store lipids when they consume more energy than they can use immediately. In mammals, adipose tissue, in addition to its role as an endocrine organ, is specialized in fat storage. Adipose tissue is mainly composed of adipocytes. Until recently, adipocytes were primarily considered mere reservoirs of energy stored as Read more…
Julien Cicero, with whom we are collaborating about the study of breast cancer metastasis mechanisms, was proud to present his PhD work during the last EACR conference. It was held in Torino (Italy) last month, during which Julien could discuss with cancer researchers from all around the world. His poster Read more…
Chez HCS Pharma, nous sommes ravis de partager avec vous les avancées significatives que nous avons réalisées dans nos projets de recherche et développement. Avant de commencer, nous tenons à remercier “La Gazette du Laboratoire” pour leur soutien continu et leur couverture détaillée de nos efforts. Notre entreprise, basée à Read more…
We are really pleased to announce that we will be present in BioAsia-Taiwan and present our breakthrough technology BIOMIMESYS alongside our partners Molecular Devices (USA) and LumiSTAR Biotechnology (TW). We are 3 companies in 3 different continents unifying their strenghs to develop the best strategy to find new and more Read more…
After Japan, the business trip has been been continued in Taïwan for several days! As a scientist, I was really happy to see such open-mind spirit when I present BIOMIMESYS technology and how this kind of technology will change the drug discovery process and help the cell therapy/regenerative medicine in Read more…
Last week, we had the pleasure to participate in the conference about Alternatives to Animal Experimentation which was held last week in Biocitech park, Romainville, France. It was organized by Adebiotech think tank, and gathered researchers from private companies and academia, and also people from organizations like FC3R and PETA Read more…
Currently in Japan, it’s already been a week in Asia. Time goes by very quickly with 3 days of events, many appointments, visits from potential partners, a visit to the Kobe biopark and JETRO, and work appointments with our privileged partner, AS ONE.The 3 days in IDDST 2023 events in Read more…
Nathalie, founder, CEO and CSO of HCS Pharma will be present in BIO international convention that takes place in Boston, USA from the 5th to the 8th of June. Is it the place to be for a start-up like HCS Pharma, proposing a breakthrough technology that will revolutionnize the biotechnology Read more…
The Building Biology in 3D symposium of the Society for Laboratory Automation and Screening (SLAS) took place in Cambridge, United Kingdom, on March 20th and 21th 2023. This congress was the opportunity to discover the dynamic scientific environment of Cambridge. Because this event was focusing on 3D cell culture, most Read more…
A driver oncogene is a gene that, when activated by mutation or altered in expression, contributes importantly to the development and progression of cancer. In other words, alteration of this kind of genes lead to the transformation of a normal cell into a cancerous cell by activating signaling pathways involved Read more…